Down-regulation of ESRP2 inhibits breast cancer cell proliferation via inhibiting cyclinD1

Caiping He, Yuting Chen, Ximin Zhang, Huancun Feng, Yuzhen Rao, Tangyang Ji, Wenya Wang · 2024

Read Down-regulation of ESRP2 inhibits breast cancer cell proliferation via inhibiting cyclinD1 by Caiping He, Yuting Chen, Ximin Zhang, Huancun Feng, Yuzhen Rao, Tangyang Ji, Wenya Wang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11574003.txt.

Description

Caiping He and co-authors examine a splicing regulator, ESRP2, and its role in breast cancer growth. Their 2024 paper notes that this protein helps decide how gene messages are cut and rejoined, and that it can either promote or restrain tumors depending on context. Its function in breast cancer, though, had not been settled.

Database analysis showed the gene runs high in breast tumors, and high levels track with shorter survival. Pathway analysis tied it to cell proliferation. In a breast cancer cell line, dialing the gene down slowed cell growth and colony formation. The effect runs through cyclin D1, a driver of the cell cycle. Chemotherapy pairing tests were also run.

Catalog record

CREATORCaiping He, Yuting Chen, Ximin Zhang, Huancun Feng, Yuzhen Rao, Tangyang Ji, Wenya Wang
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11574003

Browse the full library · About the Tower of Babel